Combination Product: Goldic serum ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 70 | Spinal stenosis | 1 |
70. Spinal stenosis
Clinical trials : 95 / Drugs : 169 - (DrugBank : 61) / Drug target genes : 68 - Drug target pathways : 90
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04492774 (ClinicalTrials.gov) | July 1, 2020 | 20/7/2020 | Degenerative Lumbar Stenosis Conservative Treatment | GOLDIC Therapy in Lumbar Degenerative Spinal Stenosis - Randomized Controlled Trial | Spinal Stenosis Lumbar;Spinal Canal Stenosis | Combination Product: Goldic serum;Drug: Steroid injections;Procedure: Manual therapy | Sutherland Medical Center | NULL | Active, not recruiting | 18 Years | N/A | All | 90 | Phase 4 | Poland |